Feasibility of Administering High-Dose131I-Mibg Therapy to Children With High-Risk Neuroblastoma Without Lead-Lined Rooms
Pediatric Blood and Cancer - United States
doi 10.1002/pbc.25892
Full Text
Open PDFAbstract
Available in full text
Date
January 15, 2016
Authors
Publisher
Wiley